Another study showed that Palbociclib treatment led to the downregulation of the DNA repair pathway and the upregulation of IL-6/STAT3 pathway, and the combination using STAT3, PARP andCDK4/6 inhibitors could target these pathways and greatly inhibit tumour growth. This evidence concerns the gene STAT3 and neoplasm.